Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
8%(1 trials)

Phase Distribution

Ph not_applicable
12
86%
Ph phase_4
2
14%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution14 total trials
Phase 4Post-market surveillance
2(14.3%)
N/ANon-phased studies
12(85.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(12)
Other(1)

Detailed Status

Completed12
Not yet recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (14.3%)
N/A12 (85.7%)

Trials by Status

completed1286%
not_yet_recruiting17%
suspended17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
14